21939743

Bayram B

2011

Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS).

21941979

I??i H

2011

Borderline micropapillary serous tumor of the ovary detected during a cesarean section due to a transabdominal cervico-isthmic cerclage in a patient with congenital cervical hypoplasia: a rare case.

21950773

Van Cauter E

2011

Sleep disturbances and insulin resistance.

21950959

Pauli JM

2011

Current perspectives of insulin resistance and polycystic ovary syndrome.

21956415

Schmidt J

2011

Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.

21958393

Costa EC

2012

Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome.

21961343

Ayala Y??ez R

2005

[Ovarian denervation and polycystic ovary].

21961344

Vadillo Buenfil M

2005

[Leptin and its influence on the main gynecoobstetric diseases].

21961995

Karabulut A

2012

Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.

21962027

Espin?s-G?mez JJ

2012

Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.

21962963

Nybacka ?

2011

Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.

21963227

Brown ZA

2011

The phenotype of polycystic ovary syndrome ameliorates with aging.

21963738

Jung JH

2011

A 27-year-old woman diagnosed as polycystic ovary syndrome associated with Graves' disease.

21966765

Mac Gregor Gooch AL

2005

[Virilizing adrenal adenoma: a report of a case].

21966797

Garc?a-Ben?tez CQ

2011

[Arterial thrombosis in ovarian hyperstimulation syndrome].

21969522

Janse F

2011

Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results.

21970545

Mohsen IA

2012

A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.

21970575

Kim JW

2012

High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome.

21970600

Misichronis G

2012

The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia.

21970639

Yun JH

2011

The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome.

21972004

Zhang XL

2012

SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients.

21972424

Sathyapalan T

2012

Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.

21974977

Eriksson O

2012

Ovarian morphology in premenstrual dysphoria.

21975377

Santos BR

2012

Vitamin D receptor gene polymorphisms and sex steroid secretion in girls with precocious pubarche in Southern Brazil: a pilot study.

21975784

Raval AD

2011

Statins for women with polycystic ovary syndrome not actively trying to conceive.

21979477

Chung PW

2011

Menstrual disorders in a Paediatric and Adolescent Gynaecology Clinic: patient presentations and longitudinal outcomes.

21982282

Velling Magnussen L

2011

Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome.

21982285

Sotomayor-Z?rate R

2011

Neonatal exposure to single doses of estradiol or?testosterone programs ovarian follicular development-modified hypothalamic neurotransmitters and causes polycystic ovary during adulthood in?the?rat.

21982726

Bizzarri C

2011

Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.

21982727

Palomba S

2011

Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in?vitro fertilization cycles: a randomized, controlled trial.

21982731

Kauffman RP

2011

Lipoprotein profiles in Mexican American and?non-Hispanic white women with polycystic ovary?syndrome.

21984038

Banerjee Ray P

2012

Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome.

21984577

Cinar N

2011

Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome.

21985780

Frigolet ME

2011

Low-carbohydrate diets: a matter of love or hate.

21986157

Demir B

2011

Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey.

21988934

Movaseghi S

2012

Clinical manifestations of the female athlete triad among some Iranian athletes.

21989557

Moran LJ

2011

Exercise decreases anti-m?llerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.

21991389

Davies MJ

2011

Intergenerational associations of chronic disease and polycystic ovary syndrome.

21992510

Hossein G

2012

Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.

21995767

Codner E

2012

Contraception, and pregnancy in adolescents with type 1 diabetes: a review.

21995801

Roesner S

2012

In vitro maturation: a five-year experience.

21996594

Koiou E

2012

Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.

21998337

Roos N

2011

Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study.

21998338

Macklon NS

2011

Polycystic ovary syndrome.

22004245

Cipkala-Gaffin J

2012

Associations between psychologic symptoms and life satisfaction in women with polycystic ovary syndrome.

22004490

Torchia D

2011

Skin manifestations of Bardet-Biedl syndrome.

22007253

Sarapik A

2012

Follicular proinflammatory cytokines and chemokines as markers of IVF success.

22008918

Al-Nuaim LA

2011

The impact of obesity on reproduction in women.

22009367

Lerchbaum E

2011

Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women.

22011217

Colonna L

2012

Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.

22014425

Liu J

2011

Mutational analysis of human bone morphogenetic protein 15 in Chinese women with polycystic ovary syndrome.

22016380

Tyndall V

2012

Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats.

22018827

Solano ME

2011

Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS).

22019619

Farhi J

2011

Novel protocol for scheduling oocyte retrieval in IVM cycles in PCOS patients: a case series.

22019891

Wei W

2012

A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.

22019954

Pesant MH

2012

Reference ranges for total and calculated free and bioavailable testosterone in a young healthy women population with normal menstrual cycles or using oral contraception.

22020578

Jeong SJ

2012

Delayed healing and induction of secretory leukocyte protease inhibitor in polycystic ovary syndrome rat skin wounds.

22023042

Mellati AA

2012

The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome.

22023105

Kostev K

2012

Unlicensed use of metformin in children and adolescents in Germany and France.

22023761

Hong Y

2011

Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.

22024243

Mohammadi A

2011

Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome.

22024419

Bruna-Catal?n I

2011

Ovulation induction with minimal dose of follitropin alfa: a case series study.

22025019

Ib??ez L

2011

Endocrinology and gynecology of girls and women with low birth weight.

22027497

Kurdoglu Z

2012

Serum trace elements and heavy metals in polycystic ovary syndrome.

22027783

Li TT

2011

[Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation].

22028409

Mahesh VB

2012

Hirsutism, virilism, polycystic ovarian disease, and the steroid-gonadotropin-feedback system: a career retrospective.

22028445

Keller J

2011

Endothelial dysfunction in a rat model of PCOS: evidence of increased vasoconstrictor prostanoid activity.

22028993

Ganie MA

2011

Polycystic ovary syndrome - A metabolic malady, the mother of all lifestyle disorders in women - Can Indian health budget tackle it in future?

22031257

Aubuchon M

2011

Polycystic ovary syndrome: current infertility management.

22031258

Casper RF

2011

Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.

22032814

Zachurzok-Buczynska A

2011

Blood pressure regulation and resting heart rate abnormalities in adolescent girls with polycystic ovary?syndrome.

22035022

Karadeniz M

2011

Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycyst?c ovary syndrome.

22043360

Shaker M

2010

Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients.

22044512

Tehrani FR

2011

The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study.

22045316

Gonz?lez F

2012

Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women.

22047005

Grundmann M

2011

Vitamin D - roles in women's reproductive health?

22052386

Sadek KH

2012

Variation in stability of housekeeping genes in endometrium of healthy and polycystic ovarian syndrome women.

22058375

Santoro N

2011

Update in hyper- and hypogonadotropic amenorrhea.

22058379

Freemark M

2011

Management of adolescents with polycystic ovary syndrome.

22058644

Dhaliwal LK

2011

Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome.

22064500

Glover J

2011

Reproductive endocrinology: adverse pregnancy outcomes in polycystic ovary syndrome.

22064667

Escobar-Morreale HF

2012

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.

22065820

Kumar P

2011

Ovarian hyperstimulation syndrome.

22067491

Onselen JV

2011

Hirsutism: causes and treatment for women.

22068557

Milutinovi? DV

2011

Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.

22068615

Sch?ring AN

2012

Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS).

22070369

Bhattacharya SM

2012

Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome.

22071112

Dikmen A

2012

Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats.

22074033

Gao L

2012

Association of the T45G and G276T polymorphisms in the adiponectin gene with PCOS: A meta-analysis.

22075350

Muolokwu E

2011

The incidence and surgical management of paratubal cysts in a pediatric and adolescent population.

22075351

Muolokwu E

2011

Paratubal cysts, obesity, and hyperandrogenism.

22076147

Xu N

2011

Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys.

22076494

Rezvanfar MA

2012

Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.

22076926

Wu S

2012

Reproductive tissues maintain insulin sensitivity in diet-induced obesity.

22077362

Yin Z

2012

Sebaceous hyperplasia within epidermis after scald.

22081247

Zhao H

2012

Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

22082203

Stovall DW

2012

Sexual function in women with polycystic ovary syndrome.

22082482

Polyzos SA

2012

The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.

22085057

Barry JA

2011

Meta-analysis of sex difference in testosterone levels in umbilical cord blood.

22086521

Montezuma T

2011

Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome.